Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

FranceBack to France

Clinical trials in Chevilly-Larue

2 clinical trials in Chevilly-Larue, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Chevilly-Larue at a glance
2
clinical trials
  • Recruiting now0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

2 trials in Chevilly-Larue

Open in trial search

Colon cancer+3

Not yet recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Abemaciclib
  • Sponsor:Institut Gustave Roussy

Breast cancer+1

Not yet recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cannabidiol
  • Sponsor:Institut Gustave Roussy

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Chevilly-Larue

What the registry says about research in the country

01 Chevilly-Larue
Musculoskeletal Pain Management in Early Breast Cancer
In Chevilly‑Larue, researchers are evaluating an oral cannabidiol (CBD) solution to alleviate musculoskeletal symptoms caused by adjuvant endocrine therapy in early breast cancer patients, aiming to improve quality of life during treatment. Comparison of CBD solution with placebo over a 12‑week period Assessment of joint pain using the Brief Pain Inventory short form Monitoring safety and tolerability of the oral formulation Potential to integrate CBD into standard supportive care regimens Positive results could offer a non‑opioid option for managing therapy‑related discomfort, supporting broader symptom‑control strategies in oncologic practice.
Integrated Geriatric Oncology Care Pathway
A collaborative study in Chevilly‑Larue examines a reinforced multi‑professional pathway that brings together oncologists, geriatricians, pharmacists, and pharmacologists to optimize oral anticancer therapy for patients aged 70 years and older. Evaluation of severe non‑hematologic and hematologic adverse events Coordination of oncogeriatric and pharmaceutical follow‑up Comparison with usual care over a 24‑month observation period Focus on diverse cancer types treated with oral agents The initiative aims to reduce treatment‑related toxicity, enhance adherence, and set a benchmark for geriatric oncology services across Europe.
Back to FranceAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.